Aura Biosciences, Inc. 10-Q filing
Filed 2026-05-11 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-216808
- Form type
- 10-Q
- CIK
- 0001501796
- Primary document
- https://www.sec.gov/Archives/edgar/data/1501796/000119312526216808/aura-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aura Biosciences, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-34.9M | - | - |
| Net Income | $-33.7M | - | - |
| Eps Basic | -0.5 | - | - |
| Eps Diluted | -0.5 | - | - |
| Cash And Equivalents | $84.8M | - | - |
| Total Assets | $137.7M | - | - |
| Total Liabilities | $30.4M | - | - |
| Shareholders Equity | $107.2M | - | - |
| Operating Cash Flow | $-29.9M | - | - |
| Capital Expenditures | $102,000 | - | - |